Auszug
Das Harnblasenkarzinom repräsentiert eine der hä-figsten onkologischen Erkrank-ngen. 130 000 Menschen versterben jährlich weltweit an einem Harnblasenkarzinom. Männer erkranken doppelt so hä-fig wie Fra-en, wobei das mittlere Erkrank-ngsalter bei 69 Jahren für Männernd bei 73.4 Jahren bei Fra-en liegt. Zahlreiche kanzerogene S-bstanzen sind identifiziert worden, de ren Expositionrsächlich mit der Entsteh-ng des Harnblasenkarzinoms vergesellschaftet ist. Allen voran ist der Zigarettenkons-m z- nennen, gefolgt von aromatischen Aminen, deren Exposition zum Teil beruflich bedingt ist. Langjähriger Phenacetinabusus oder eine Strahlentherapie können Tumoren der Harnblase entstehen lassen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aghaji AE, Mbonu OO (1989) Bladder tumors in Enugu, Nigeria. Br J Urol 64: 399
Anderström C, Johansson SL, van Schulz L (1983) Primary adenocarcinoma of urinary bladder. Cancer 52: 1273
Babaya K, Takahashi S, Momose H et al. (1987) Effects of single chemotherapeutic agents in development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats. Urol Res 15: 329–334
Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Medsger TA (1987) Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-result follow-up study. Am J Med; 83: 1–9
Bedwani R, Renganathan E, El Kwhsky F et al. (1998) Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 77(7): 1186–1189
Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, et al.(2000) Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer.; 86: 289–294
Case RAM, Pearson JT (1954) Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part II: Further consideration of the role of aniline and of the manufacture of auramine and magenta (fuchsine) as possible causative agents. Br J Ind Med 11: 213
Cole P (1971) Coffee-drinking and cancer of the lower urinary tract. Lancet I: 1335
Coleman M, Babb P, Damiecki P, Grosclaude P, Honjo S, Jones J, Knerer G, Pitard A, Quinn M, Scoggett A, De Stavoua B (1999) Cancer Survival Trends in England and Wales, 1971-1995: Deprivation and NHS Region. London: The Stationary Office
Deutz FJ, Rübben H, Küpper W, Hofstädter F (1988) Morphologie der Harnblase und des Darms nach Harnleiter-Sigmaimplantation unter Karzinogenexposition. 9. Symposium Experimentelle Urologie. Aachen, 16.-18.6
Donato F, Boffetta P, Fazioli R, Gelatti U, Porru S (1998) Reliability of data on smoking habit and coffee drinking collected by personal interview in a hospital-based case-control study. Eur J Epidemiol 14(3): 259–267
Fairchild WV, Spence CR, Solomon HD, Gangai MP (1979) The incidence of bladder cancer after cyclophosphamide therapy. J Urol 122: 163
Gonheim MA, Ashamallah AK, Awaad HK, Whitemore WF Jr (1985) Randomized trial with cystectomy with preoperative radiotherapy for carcinoma of the bilharzial bladder. J Urol 134: 266
Gonwa TA, Corbett WT, Schey HM, Buckalew VM (1980) Analgesic associated nephropathy and transitional cell carcinoma of the urinary tract. Ann Intern Med 93: 249
Hecht SS, Tso TC, Hoffmann D (1976) Selective reduction of tumorgenicity of tobacco smoke. IV Approaches to the reduction of N-nitrosamines and aromatic amines. Proceedings of Third World Conference o smoking and health. Dept Health Education and Welfare Publ No (NIH) 76: 535
Hicks RM, Walters CL, El Sebai I, El Asser AB, El Merzabani M, Grough TA (1977) Demonstration of nitrosamines in human urine. Preliminary observations on a possible aetiology for bladder cancer in association with chronic urinary tract infection. Proc R Soc Med 70: 413
Hoffmann D, Masuda Y, Wynder EL (1969) Alpha-naphthylamine and beta-naphthylamine in cigarette smoke. Nature 221: 254
Hueper WC, Wiley FH, Wolfe HD (1938) Experimental production or bladder tumours in dogs by administration of beta-naphthylamine. J Indust Hyg Toxiol 20/1: 46
Irving CC, Murphy WM, Damil DS (1984) Comparative carinogenicity of N-Butyl-N-(3 carboxypropyl)-Nitrosamin and N-Butyl-N(4 hydroxybutyl) nitrosamine for the urinary bladder of (C5BL/6×DBA/2)F1 mice. JNCI 73/3: 753–756
Ito N (1984) Histogenesis of urinary bladder tumors induced by nitrosamine in rats. J Cancer Res Clin Oncol 108: 169–173
Ito N (1988) Early changes caused by nitrosamine in the bladder epithelium of different animal species. Jpn J Cancer Res 79(4): 413–417
Jakse G, Jakobi GH, Altwein JE (1979) Das Adenokarzinom der Harnblase. Urologe A18: 86
Johansson SL, Cohen SM. (1997) Epidemiology and etiology of bladder cancer. Semin Surg Oncol.; 13: 291–298
Johnson DE, Schoenwald MB, Ayala AG, Miller LS (1976) Sqamous cell carcinoma of the bladder. J Urol 115:542
Kaufmann JM, Fam B, Jacobs SC, Gabrilondo F, Yalla S, Kane JP, Rossier AB (1977) Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 118: 967
Kunze E, Calude J, Frentzel-Beyme R (1986) Associalion of cancer ot the lower urinary tract with consumption of alcoholic beverages — a case control study. Carcinogenesis 7: 163
Linn JFJ, Rübben H. (1995) Die Wirkung von Keyhole-Limpet-Haemocyanin auf chemisch induzierte Blasentumore bei Ratten. Vergleich subkutaner vs. intraversikaler Applikation vs. Kontrollgruppe. 12. Symposium für experimentelle Urologie. 18.03.95, Berlin
Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, et al. (2000) Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev. 9: 461–467
McCredie M, Stewart JH, Ford JM, McLennan RA (1983); Phenacetin containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol; 55: 220–224
Micheli A, Mariotto A, Giorgio Rossi A, Gatta G, Muti P (1998) Eurocare Working Group, The prognostic role of gender in survival of adult cancer patients. Eur J Cancer; 14: 2271–2278
Morrison AS, Cole P (1982) Urinary tract. In: Schottenfeld D, Fraumeni FJ, Saunders WB (eds) Cancer epidemiology and prevention. Saunders, Philadelphia, p. 925
Mostafa MH, Helmi S, Badawi AF, Tricker AR, Spiegelhalder B, Preussmann R (1994) Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schisto soma mansoni infected patients. Carcinogenesis; 15: 619–625
Norpoth K, Woitowitz HJ (1994) Beruflich verursachte Tumoren. Dt. Ärzte Verlag, Köln, S. 25–31
Ohkawa T, Fujinaga T, Doi J, Ebisuno S, Takamatsu M, Nakamura J, Kido R (1982) Clinical study on occupational uroepithelial cancer in Wakayama City. J Urol 128: 520
Olsen CA, Vere White RW de (1979) Cancer of the bladder. In: Javadpour N (ed) Principles and management of urologic cancer. Williams & Wilkins, Baltimore, p. 337
Parkin DM, Bray F, Ferley J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer Oct 15,94(2): 153–6
Pashos CL, Botteman MF, Laskin BL, Redaelle A; Bladder cancer (2002) Epidemiology, Diagnosis and Management Cancer Practice Nov/Dec; 10(6): 311–322
Patterson JM, Ray EH, Mendiondo OA, Medina WD, Gee WF (1988) A new treatment for invasive sqamous cell bladder cancer: the nigro regimen:preoperative chemotherapy and radiation therapy. J Urol 140: 379
Patrianakos C, Hoffmann D (1979) Chemical studies on tobacco smoke. LXIV On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 3: 150
Pearson RM, Soloway MS (1978) Does cyclophosphamide induce bladder cancer? Urology 4: 437
Pedersen-Bjergaard J, Ersboll J, Hansen VL et al. (1988); Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin lymphoma. N Engl J Med 318: 1028–1032
Petkovic S, Multavdzik M, Petronic V, Marcovic V (1971) Tumours of the renal pelvis and ureter: clinical and aetiologic studies. J Urol Nephrol (Paris) 77: 429
Probert JL, Persad RA, Greenwood RP, Gillatt DA, Smith PJ (1998) Epidemiology of transitional cell carcinoma of the bladder: profile of an urban population in the south-west of England. Br J Urol 82(5): 660–666
Quilty PM, Duncan W (1986) Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int J Radiat Oncol Biol Phys 12: 853
Raghavan D, Huben R, (1995) Management of bladder cancer Curr Probl Cancer 19: 1–64
Rathert P, Melchior HJ, Lutzeyer W (1975) Phenacetin: A carcinogen for the urinary tract? J Urol 113: 653–658
Richter J, Jiang F, Görög J, Sartorius G, Moch H, Egenter C, Gasser T, Mihatsch M, Sauter G (1997) Marked genetic differences between pTa and pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res.; 57: 2860–2864
Richter J, Beffa L, Wagner U, Schraml P, Gasser T, Moch H, Mihatsch M, Sauter G (1998) Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by CGH. Am J Pathol;153: 1615–1621
Riede UN, Schaefer HE (1995) Allgemeine und spezielle Pathologie. Georg Thieme Verlag, Stuttgart, New York
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. (2000) SEER Cancer Statistics Review, 1973-1997. Bethesda, Md: National Cancer Institute
Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK (eds) (1999) SEER Cancer Statistics Review, 1973-1996. Bethesda MD: National Cancer Institute. NIH; Pub. No. 99-2789
Rosin MP, Caims P, Epstein JI, Schoenberg MP, Sidransky D (1995) Partial allelotype of carcinoma in situ of the human bladder. Cancer Res 55: 5213–5216
Sadetzki S, Bensal D, Blumstein T, Novikov I, Modan B (2000) Selected risk factors for transitional cell bladder cancer. Med On col.; 17: 179–182
Schulte PA, Ringen K, Hemstreet GP (1986) Risk factors for bladder cancer in cohort exposed to aromatic amines, Cancer 58: 2156
Sen SE, Malek RS, Farrow GM, Lieber MM (1985) Sarcoma and carcinosarcoma of the bladder in adults. J Urol 133: 29–30
Sherif A, De la Torre M, Maömström PU et al. (2001) Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol 166: 812–815
Silverman DT, Hartge P, Morrison AS, Devesa SS (1992) Epidemiology of bladder cancer. Hematol Oncol Clin North Am 3: 421–428
Simon R, Bürger H, Brinkschmidt C, Böcker W, Hertle L, Terpe H (1998) Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol; 185: 345–351
Shibata MA et al. (1989) The role of BBN in F344 rats. J Toxicol Environ Health 26(3): 255–265
Tyrkus M, Powell I, Fakr W (1992) Cytogenetic studies of carcinoma in situ of the bladder: prognostic implications. J Urol;148: 44–46
Vineis P, Pirastu R (1997) Cancer Causes Control 8: 346–355
Wynder EL, Goldsmith R (1977) The epidemiology of bladder cancer: a second look. Cancer 40: 1246
Zeegers MPA, Kellen E, Buntinx, Brandt van den PA (2004) The association between smoking, beverage consumption, diet and bladder cancer: a systemic literature review. World J Urol 21: 392–401
Zhao J, Richter J, Wagner U, Roth B, Schraml P, Zellweger T, Ackermann D, Schmid U, Moch H, Mihatsch MJ, Gasser TC, Sauter G (1999) Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res. 59: 4685–4661
Zheng W, McLaughlin JK, Gao YT, Silverman DT, Gao RN, Blot WJ (1992) Bladder cancer and occupation in Shanghai, 1980-1984. Am J Ind Med. 21: 877–885
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
vom Dorp, F. (2007). Epidemiologie, Ätiologie und Klassifikation des Harnblasenkarzinoms. In: Rathert, P., Roth, S. (eds) Urinzytologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-31041-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-540-31041-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-31038-9
Online ISBN: 978-3-540-31041-9
eBook Packages: Medicine (German Language)